Journal Ranking

Unranked

Not Yet Ranked

Quality metrics need to be calculated to establish ranking.

Recent Activity

Page Views (30d) 12

Unique Visitors 12

the lancet oncology

Indexings	scopus ncbi
Short Name	lancet oncol
Abbreviated Name	lancet oncol
ISSN	1474-5488
Aim and Scope
URL
Author Instructions

Publications Per Year

Recent Articles (9 total)

2017

Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study

Chiappella A;Martelli M;Angelucci E;Brusamolino E;Evangelista A;Carella AM;Stelitano C;Rossi G;Balzarotti M;Merli F;Gaidano G;Pavone V;Rigacci L;Zaja F;D'Arco A;Cascavilla N;Russo E;Castellino A;Gotti M;Congiu AG;Cabras MG;Tucci A;Agostinelli C;Ciccone G;Pileri SA;Vitolo U;;

Vol. 18 , No. 8 , pp. -

393 views Abstract

2019

Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis.

Giuliano, Mario;Schettini, Francesco;Rognoni, Carla;Milani, Manuela;Jerusalem, Guy;Bachelot, Thomas;De Laurentiis, Michelino;Thomas, Guglielmo;De Placido, Pietro;Arpino, Grazia;De Placido, Sabino;Cristofanilli, Massimo;Giordano, Antonio;Puglisi, Fabio;Pistilli, Barbara;Prat, Aleix;Del Mastro, Lucia;Venturini, Sergio;Generali, Daniele;

287 views DOI Abstract

2016

Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study.

Dimopoulos, Meletios A;Moreau, Philippe;Palumbo, Antonio;Joshua, Douglas;Pour, Ludek;Hájek, Roman;Facon, Thierry;Ludwig, Heinz;Oriol, Albert;Goldschmidt, Hartmut;Rosiñol, Laura;Straub, Jan;Suvorov, Aleksandr;Araujo, Carla;Rimashevskaya, Elena;Pika, Tomas;Gaidano, Gianluca;Weisel, Katja;Goranova-Marinova, Vesselina;Schwarer, Anthony;Minuk, Leonard;Masszi, Tamás;Karamanesht, Ievgenii;Offidani, Massimo;Hungria, Vania;Spencer, Andrew;Orlowski, Robert Z;Gillenwater, Heidi H;Mohamed, Nehal;Feng, Shibao;Chng, Wee-Joo;, ;

Vol. 17 , No. 1 , pp. 27-38

284 views DOI Abstract

2016

Erlotinib, cabozantinib, or erlotinib plus cabozantinib as second-line or third-line treatment of patients with EGFR wild-type advanced non-small-cell lung cancer (ECOG-ACRIN 1512): a randomised, controlled, open-label, multicentre, phase 2 trial.

Neal, Joel W;Dahlberg, Suzanne E;Wakelee, Heather A;Aisner, Seena C;Bowden, Michaela;Huang, Ying;Carbone, David P;Gerstner, Gregory J;Lerner, Rachel E;Rubin, Jerome L;Owonikoko, Taofeek K;Stella, Philip J;Steen, Preston D;Khalid, Ahmed Ali;Ramalingam, Suresh S;, ;

Vol. 17 , No. 12 , pp. 1661-1671

249 views DOI Abstract

2020

Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative report.

Armstrong, Terri S;Dirven, Linda;Arons, David;Bates, Amanda;Chang, Susan M;Coens, Corneel;Espinasse, Claire;Gilbert, Mark R;Jenkinson, David;Kluetz, Paul;Mendoza, Tito;Rubinstein, Larry;Sul, Joohee;Weller, Michael;Wen, Patrick Y;van den Bent, Martin J;Taphoorn, Martin J B;

Vol. 21 , No. 2 , pp. e97-e103

247 views DOI Abstract

2020

Radiotheranostics: a roadmap for future development.

Herrmann, Ken;Schwaiger, Markus;Lewis, Jason S;Solomon, Stephen B;McNeil, Barbara J;Baumann, Michael;Gambhir, Sanjiv S;Hricak, Hedvig;Weissleder, Ralph;

Vol. 21 , No. 3 , pp. e146-e156

213 views DOI Abstract

2013

Is India ready to lead the battle for fair access to medicines?

Lancet Oncology, ;

Vol. 14 , No. 6 , pp. 437

200 views DOI

2019

Erratum: Correction to Lancet Oncol 2019; 20: 408-19 (The Lancet. Oncology (2019) 20 3 (408-419) PII: S1470-2045(19)30587-X)

not, found

Vol. 20 , pp. e559

174 views DOI

2010

Pancreatic cancer: a neglected killer?

Lancet Oncology, ;

Vol. 11 , No. 12 , pp. 1107

169 views DOI

Overall

Not Rated

Journament